Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis effects on mobility and cognition in older women with HIV
NCT03633721Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Oct 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabis, sponsored by Albert Einstein College of Medicine. Primary endpoint: Mobility Gait Speed. Started Oct 2020; status: completed.
02
Drugs
cannabis
Beyond the preview
Go deeper on NCT03633721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633721.